We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App





Snibe Showcases Maglumi X3 Fully Automatic CLIA System at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 12 Apr 2022

Snibe (Shenzhen, China) showcased its new fully automatic Chemiluminescence Immunoassay (CLIA) system at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, EUROMEDLAB 2022, in Munich, Germany. More...

EUROMEDLAB is the most influential platform in Europe where new ideas and technologies in laboratory diagnostics are shared and showcased.

At EUROMEDLAB 2022, Snibe demonstrated its new Maglumi X3 fully automatic CLIA system that is small but powerful, with a throughput of up to 200 tests per hour and a throughput per unit area is 294 tests per hour/m². One of the highest space efficiency CLIA analyzers, the Maglumi X3 combines one of the broadest automated CLIA test menus (181 parameters) and is compatible with all Maglumi reagents.

Its single reaction cup can avoid light pollution and increase cuvette utilization, while its integrated packaging can prevent the cuvette from sticking and destroying the cuvette wall. The MAGLUMI X3 features pipetting detection technologies such as liquid level, clot, and crash detection to ensure accurate and normal pipetting. It features the latest intelligent washing technology and bidirectional temperature control measurement to guarantee accurate and reliable results. With its advanced design, intelligent UI interface, user-friendly, easy, and convenient operation, the MAGLUMI X3 ensures excellent performance and is ideal for small and medium-sized hospitals and laboratories.

Related Links:
Snibe 


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
HAV Rapid Test
OnSite HAV IgG/IgM Rapid Test
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.